Preparative Cytoreductive Surgery in Patients with Metastatic Renal Cell Carcinoma Treated with Adoptive Immunotherapy with Interleukin-2 or Interleukin-2 Plus Lymphokine Activated Killer Cells-Reference-Cited by-同舟云学术

Preparative Cytoreductive Surgery in Patients with Metastatic Renal Cell Carcinoma Treated with Adoptive Immunotherapy with Interleukin-2 or Interleukin-2 Plus Lymphokine Activated Killer Cells

Published:1990-09 Issue:3 Volume:144 Page:614-617
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Robertson Cary N.¹,Linehan W. Marston¹,Pass Harvey I.¹,Gomella Leonard G.¹,Haas Gabriel P.¹,Berman Arlene¹,Merino Maria¹,Rosenberg Steven A.¹

Affiliation:

1. From the Surgery Branch, Division of Cancer Treatment and Laboratory of Pathology, and Division of Cancer Biology and Diagnosis, National Cancer Institute, Bethesda, Maryland

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference17 articles.

1. Cancer of the kidney and ureter;Linehan,1989

2. Renal tumors;deKernion,1986

3. 1986 Annual Cancer Statistics Review. Bethesda: NIH publication No. 87-2789, 1986.

4. Renal cell carcinoma: survival and prognostic factors;Golimbu;Urology,1986

5. Interferon-alpha therapy of renal cancer;Neidhart;Cancer Res.,1984

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytoreductive nephrectomy in metastatic renal cell carcinoma;Cochrane Database of Systematic Reviews;2024-06-07

2. Understanding and integrating cytoreductive nephrectomy with immune checkpoint inhibitors in the management of metastatic RCC;Nature Reviews Urology;2023-07-03

3. Is Cytoreductive Nephrectomy Still Beneficial for Patients With Metastatic Renal Cell Carcinoma in the Contemporary Immunotherapy Era?;The Korean Journal of Urological Oncology;2022-08-31

4. Outcomes following cytoreductive nephrectomy without immediate postoperative systemic therapy for patients with synchronous metastatic renal cell carcinoma;Urologic Oncology: Seminars and Original Investigations;2022-04

5. New Developments in T Cell Immunometabolism and Implications for Cancer Immunotherapy;Cells;2022-02-17